Results 121 to 130 of about 24,071 (243)

Anatomical and functional response after conversion to aflibercept using the treat-and-extend regimen protocol in bevacizumab treatment-resistant wet age-related macular degeneration

Clinical Ophthalmology, 2018
Claudia Taipale,1,2 Ilkka Laine,1,3 Raimo Tuuminen1,3 1Helsinki Retina Research Group, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland; 2Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland; 3Department of
Taipale C, Laine I, Tuuminen R
doaj  

Trattamento con FOLFIRI e aflibercept in paziente con adenocarcinoma del colon destro RAS e BRAF wild-type e metastasi epatiche potenzialmente resecabili [PDF]

, 2018
Filippo Pietrantonio
openalex   +1 more source

Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial [PDF]

, 2020
Masaru Inatani, Tomomi Higashide, Kenji Matsushita, Atsuya Miki, Mari Ueki, Y. Iwamoto, Masato Kobayashi, Sérgio Leal, Sergio Leal   +8 more
openalex   +1 more source

Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study [PDF]

, 2022
Lihteh Wu, Arnaldo Furman Bordon, Martin Charles, Francisco J. Rodríguez, JinKyung Lee, Tobias Machewitz, Margarete Mueller, Gabriela del Carmen Gay, Jans Fromow-Guerra, the AQUILA investigators   +9 more
openalex   +1 more source

Aflibercept Action in a Rabbit Model of Chronic Retinal Neovascularization: Reversible Inhibition of Pathologic Leakage With Dose-Dependent Duration

, 2018
Jingtai Cao, Thomas MacPherson, Bibiana V. Iglesias, Yang Liu, Natasha Tirko, George D. Yancopoulos, Stanley J. Wiegand, Carmelo Romano   +7 more
openalex   +1 more source

Exacerbation of pigment epithelial detachment following aflibercept: A case of bevacizumab rescue

, 2021
Samaneh Davoudi, Ramak Roohipourmoallai, Cynthia Guerin, Siva S.R. Iyer   +3 more
openalex   +1 more source

Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product

Ophthalmology and Therapy
Introduction ABP 938 is being developed as a biosimilar candidate to aflibercept reference product (RP), a biologic used for certain angiogenic eye disorders.
Neungseon Seo, Xiaoyan Guan, Tian Wang, Hyo S. Helen Chung, Mats Wikström, Rupa Padaki, Kevin Kalenian, Scott Kuhns, Kelli Matthies, Jill Crouse-Zeineddini, Helen Y. Wong, Michael Ng, Ian N. Foltz, Shawn Cao, Jennifer Liu   +14 more
doaj   +1 more source

Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome

, 2016
Sleiman Abou-Ltaif
openalex   +1 more source

Alexandrite Laser-Induced Choroidal Neovascularization Successfully Treated With Aflibercept [PDF]

, 2020
Asterios Diafas, Despoina Stampouli, Άννα Δαστιρίδου, Sofia Androudi, Periklis Brazitikos   +4 more
openalex   +1 more source

Aflibercept – How does it compare with other Anti-VEGF Drugs?

, 2015
Raj Sharma Yog, Tripathy Koushik, Venkatesh Pradeep, Gogia Varun   +3 more
openalex   +1 more source